A Singapore Government Agency Website
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites

Secure websites use HTTPS

Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Scam alert

Government officers will never ask you to send money or share your details over the phone. When unsure, hang up and call Scamshield at 1799.
 

PRECISE-SG100K Projects

(Precision Health Research, Singapore)

Discover the projects at the heart of Singapore's precision health research, unlocking new insights across diverse disease areas with the PRECISE-SG100K dataset.

Last updated 24 days ago (29 Oct 2026)

Data explorer

PRECISESG100KProjects.csv (65 rows, 100.1 KB)

No
Text
Project Title And Team
Text
Project Description
Text
(Null)0.0%
(Null)0.0%
(Null)0.0%
1Advancing Precision Medicine for Cardiovascular Disease and Diabetes in Asian Populations Lead PI: Prof John Chambers, Lee Kong Chian School of Medicine Co-Lead PI: A/Prof Sim Xueling, National University of Singapore Co-Lead PI: Prof Cheng Ching-Yu, Duke-NUS Medical School Co-Lead PI: Prof Yeo Khung Keong, National Heart Centre SingaporeCardiovascular disease and diabetes are major causes of ill health in Singapore and across Asia. Asian populations have distinct cardiometabolic risk profiles, yet remain underrepresented in many large-scale genomic and population health studies. The SG100K study provides an important opportunity to address this gap through a large, deeply characterized, multi-ethnic Asian population cohort. SG100K brings together extensive information on participants’ health and lifestyle, physical measurements, imaging and biological samples. Through the PRECISE-SG100K collaboration, these rich cohort data are complemented by whole-genome sequencing and linkage to longitudinal health records, creating a powerful resource for precision medicine research in Asian populations. Using the PRECISE-SG100K resource, this study will investigate the behavioral, environmental, clinical and molecular factors that contribute to cardiovascular disease and diabetes. The research will examine how diet, physical activity, sociodemographic characteristics and environmental exposures influence cardiometabolic health, alongside genomic and molecular analyses to identify biomarkers of disease risk, understand biological pathways involved in disease development and progression, and improve approaches to risk prediction. By integrating population health, genomic and molecular data at scale, the study aims to generate insights that are particularly relevant to Asian populations. Ultimately, the research aims to improve risk stratification, identify opportunities for prevention and therapeutic intervention, and support more precise and personalized approaches to preventing cardiovascular disease and diabetes in Singapore and beyond.
2The SG100K Cognitive Health Programme Lead PI: Adj Asst Prof Max Lam, Lee Kong Chian School of Medicine Co-Lead PI: A/Prof Jimmy Lee, Institute of Mental Health Co-Lead PI: Prof Liu Jianjun, A*STAR Genome Institute of SingaporeResearch has persistently highlighted the genetic underpinnings of cognitive performance, and cognitive deficits have emerged as a profound component of the functional impairments associated with mental illnesses, cardiometabolic disease and neurodegenerative disorders. The investigation of cognition and its association with related disease traits could facilitate better understanding of cognitive health and related treatment strategies. Despite Asians comprising a significant portion of the world’s population, large-scale efforts to study cognitive genomics in non-European populations are conspicuously absent. The SG100K cohort, as the only national biobank in Asia conducting cognitive phenotyping, presents an unparalleled opportunity to fill this gap and extend our understanding of cognitive dysfunction and disease manifestation across populations. The aim of the present study is three-fold: (i) to identify novel genomic loci associated with cognitive phenotypes and establish the genetic underpinnings of cognitive function across diverse populations; (ii) to establish biological convergence between cognitive function and disease traits; (iii) to establish epidemiological and genomic risk prediction of cognitive health.
3The SG100K_Med Alliance - Clinical Genetics Researchers United for the Analysis of Mendelian Disease Variation in SG100K Lead PI: Asst Prof Lim Weng Khong, Duke-NUS Medical School Co-Lead PI: A/Prof Joanne Ngeow, Lee Kong Chian School of Medicine Co-Lead PI: A/Prof Saumya Jamuar, Duke-NUS Medical SchoolThe project seeks a deeper understanding of genetic disease burden in major Asian populations through a larger, balanced cohort and uniform 30X Whole Genome Sequencing (WGS). Going beyond SNVs/indels, it includes a comprehensive analysis of structural variation and short tandem repeat (STR) expansions. Leveraging research phenotypes and electronic health records, the group will demonstrate how SG100K data can resolve variants of uncertain significance (VUS). The study will also explore the impact of polygenic backgrounds on penetrance in autosomal dominant conditions for under-represented Asian populations, where the applicability of findings from European ancestry populations is unclear. The project aims to characterize the influence of polygenic backgrounds on conditions like hereditary breast and ovarian cancer, hypertrophic cardiomyopathy, and familial hypercholesterolemia. Additionally, the research addresses the return of results for a subset of SG100K participants, recontacting those with reportable variants (CDC Tier 1 and certain inherited cardiac conditions). Outcomes will be presented in terms of response rates and the impact on risk management, providing practical insights into returning results within genetic research.
4Identification of Asian-specific Genetic Association with Fat and Lean Muscle Mass Distribution Lead PI: Asst Prof Liu Boxiang, National University of Singapore Co-Lead PI: A/Prof Sim Xueling, National University of Singapore Co-Lead PI: Prof Tai E Shyong, National University of SingaporePrevious body composition GWAS studies have been limited to the European population and relied on waist-hip ratio measurements without incorporating functional imaging or whole genome sequencing. However, this study aims to identify genetic risk loci specific to Asian populations associated with fat and lean muscle mass distribution and their role in cardiometabolic diseases. We will use deep-learning based image segmentation and pattern recognition to analyze DEXA scans and obtain precise measurements of fat and lean muscle mass. By focusing on the SG100K dataset and integrating it with the UK Biobank (UKBB), we address the unique genetic makeup of Asian populations, which are underrepresented in current genetic research. Through a multi-ethnic meta-analysis and Mendelian randomization, we will discover common and rare genetic variants affecting body composition with causal relationships with cardiometabolic diseases. Colocalization analysis will further link risk genes with disease traits, followed by functional validation to confirm mechanistic links. The findings are expected to enhance early detection, prevention and targeted treatment strategies for cardiometabolic conditions, ultimately contributing to more inclusive and precise public health interventions. This research underscores the importance of diversity in genetic studies and aims to fill critical gaps in our understanding of genetic influences on metabolic health in Asian populations.
5HLA alleles and its Association with Auto-immune Diseases and Pharmacogenomics in Multi-Ancestral Asian Populations Lead PI: A/Prof Sim Xueling, National University of Singapore Co-Lead PI: Adj A/Prof Leong Khai Pang, Tan Tock Seng Hospital Co-Lead PI: Dr Wharton Chan, Duke-NUS Medical SchoolA person died because their body rejected a transplanted organ. Someone with lupus had joint inflammation that made movement difficult. A child had severe anemia caused by malaria. Another child got a serious infection due to a weak immune system. A patient had a dangerous skin reaction after taking a certain medication. What do all these cases have in common? They all involve problems with the body’s immune system, specifically the human leukocyte antigen (HLA) system, which helps the body recognize what belongs and what doesn’t. When the HLA system malfunctions, it can lead to serious health issues. The HLA system is a set of genes on chromosome 6 that helps the immune system recognize threats. It contains over 200 genes, many of which vary between people, affecting disease risk and drug responses. For example, people with the HLA-B*1502 gene can have a severe reaction to the drug carbamazepine, so genetic testing is required in Singapore before prescribing it. Studying 50,000 Asian individuals can help us better understand how HLA genes affect health.
6Unraveling the Determinants of Kidney Health in a Multi-Ethnic Asian Population Lead PI: A/Prof Yeo See Cheng, Tan Tock Seng Hospital Co-Lead PI: Prof John Chambers, Lee Kong Chian School of MedicineKidney damage and loss of kidney function is a common and serious health problem in Singapore. Currently, there is limited understanding from studies conducted in Singapore as to why kidney disease is more common here, why some groups are more affected, and how risk factors such as diabetes, high blood pressure, lifestyle, environment and other factors can be linked to kidney disease. It is also not clear if our genes plays an important role for determining risk of kidney disease. A better understanding of these factors predicting kidney disease will allow for policies and strategies aimed at prevention, early detection, better risk assessment and effective treatment of kidney disease. These will then prevent kidney failure and serious problems due to kidney disease, reduce need for dialysis treatment and improve general kidney health of the population. In this project, we aim to determine the frequency of kidney disease in different groups, study the link between kidney disease with genes, chronic diseases, lifestyle and environmental factors in each group, the relative contribution of these factors driving differences in kidney disease risks across different groups, and develop an individualised risk assessment for the prevention and treatment of kidney disease in Singapore.
7The High Variability of Tandem Repeats Offers Insights into Population Diversity and may Explain the Missing Heritability of Complex Neurological and Neurocognitive Disorders in Asian Populations Lead PI: Prof Liu Jianjun A*STAR Genome Institute of Singapore Co-Lead PI: Dr Nicolas Bertin, A*STAR Genome Institute of Singapore Co-Lead PI: Asst Prof Lim Weng Khong, Duke-NUS Medical SchoolTandem repeats (TRs) are highly polymorphic repetitive DNA sequences that account for approximately 3% of the human genome. Expansions of repeats, i.e., having excess number of TR units, are clinically relevant to more than 40 types of Mendelian disorders, primarily affecting the neurological system. For example, Huntington’s disease is caused by the expansion of CAG repeats located in the HTT gene. However, our understanding of TRs in large-scale populations, particularly among Asians, is limited. This knowledge gap has hindered further research into the role of TRs in complex diseases. By leveraging the PRECISE-SG100K dataset that includes (i) population-scale whole genome sequencing data and (ii) comprehensive health and well-being questionnaires, along with clinically acquired phenotypes, we aim to comprehensively identify TR variations and their contributions to the aetiology of complex neurological and neurocognitive disorders in Singapore Asian populations. We will utilize various bioinformatics methods, including TR genotyping tools to characterize TR variations and Genome-Wide Association Studies (GWAS) to explore the relationship between TRs and diseases. Our research will enhance the understanding of TR variations in Asian populations and potentially stimulate further research into complex diseases from the perspective of TRs, ultimately helping to unravel the genetic mechanisms underlying these conditions.
8An Integrated Pharmacoeconomic-Pharmacokinetic Framework for Prioritising and Testing Clinically Important Drug-Gene Interactions Lead PI: Dr Janice Goh, A*STAR Bioinformatics Institute Co-Lead PI: A/Prof Wee Hwee Lin, National University of Singapore Co-Lead PI: Dr Nicolas Bertin, A*STAR Genome Institute of SingaporePharmacogenetics (PGx) testing is emerging as a promising approach to inform precise and optimal medication decisions. However, there is a paucity of data examining the utility of these guidelines in Asian populations as the vast majority of known PGx associations were discovered in populations of European descent. Leveraging on the SG100K database, we thus aim to develop comprehensive research findings on the prevalence of clinically actionable drug-gene interactions and recommend dosing changes tailored to our Singaporean population appropriate for age, weight and renal function, or that should warrant further clinical investigation. This will be done using the following aims: 1) Evaluate the occurrence of known drug-gene interactions based on EHR data and its impact on efficacy and toxicity 2) Explore genotype-drug response associations using SG100K and linked EHR datasets augmented by a dedicated pipeline for haplotyping highly polymorphic drug metabolizing enzyme CYP2D6 3) Develop a pharmacokinetics-informed framework for evaluating and ranking both known and novel drug-gene sets for clinical action to make dose recommendations Together, we aim to give clarity to the clinically important drug-gene interactions in Asians, and how to manage them.
9Genetic Variants Contributing to Clonal Haematopoiesis across Diverse Asian Genomes Lead PI: Prof Ong Sin Tiong, Duke-NUS Medical School Co-Lead PI: Prof Ashok Vekitaraman, National University of Singapore Co-Lead PI: Prof Chng Wee Joo, National University of Singapore Co-Lead PI: Prof John Chambers, Lee Kong Chian School of Medicine Co-lead PI: Dr Nicolas Bertin, A*STAR Genome Institute of SingaporeAge-related acquisition of somatic mutations occurs in all tissues, particularly in bone marrow haematopoietic stem cells (HSC), which is referred to as clonal haematopoiesis (CH). Due to the systemic nature of blood and the immune system it gives rise to, CH confers an increased risk of developing coronary artery and heart diseases, lung and myeloproliferative cancers and worsening prognosis for cancer or infectious diseases, such as COVID-19. The prevalence and aetiology of CH and related conditions have been mostly studied in populations of Caucasian ancestry. Little is known of CH prevalence and the spectrum of CH driver mutations in Asian populations, or of the prevalence of germline variants (including Asian-specific variants) conferring an increased risk of developing CH. Using SG100K population-scale clinical-grade whole genome sequencing (WGS) we aim to identify and estimate the prevalence of CH driver mutations in our local populations. Having identified CH-affected individuals, we will then proceed to identify CH risk factor variants. We will also correlate CH status with clinical metadata, measures of ageing as well as disease incidence and other disease-related biomarkers. To link CH-related phenotypes to cellular and molecular readouts, individuals with CH who have had scRNA-sequencing performed on their peripheral blood, as part of the Asian Immune Diversity Atlas (AIDA), will be analysed to identify cell types, cell states, and gene expression programmes that correlate with CH-related features. In addition, copy number variants (CNVs) inferred from AIDA data at single-cell resolution could corroborate clone size estimates derived from SG100K WGS data..
10Computation of Genome-Wide LD Scores and Matrices from the SG100K resource Lead PI: Li Jingmei, A*STAR Genome Institute of Singapore Co-Lead PI: Rajkumar s/o Dorajoo, A*STAR Genome Institute of Singapore Co-Lead PI: Khor Chiea Chuen, A*STAR Genome Institute of SingaporeLinkage disequilibrium score regression (LDSC) is a technique in genetics used to understand how different factors, including genetic effects and confounding elements like population differences, contribute to the results of genome-wide association studies (GWAS). Essentially, LDSC uses regression analysis to examine the relationship between linkage disequilibrium (LD) scores and statistical results from GWAS. An LD score for a single-nucleotide polymorphism (SNP) is the sum of how much this SNP is linked to other SNPs. LDSC helps estimate how much of a trait’s heritability (genetic contribution) can be attributed to SNPs, separate this heritability into different categories, and calculate genetic correlations between various traits. It is particularly effective with large datasets because it only needs summary statistics from the entire GWAS. Taking reference from similar work performed by the Pan-UK Biobank, we will compute insample dosage-based LD matrices and scores for each of the three major ancestry groups in SG100K. With these LD resources, it is possible to re-analyze Asian GWAS results, including: – LD score regression analysis to estimate heritabilities – Fine-mapping analysis to identify causal variants of well-powered complex traits The plan is to make the LD matrices available in Hail’s BlockMatrix format or similar. LD scores will also be available in LDSC-compatible flat files (.l2.ldscore.gz and .M_5_50).
Google colab link
Analyse this dataset with Colab Notebook
  1. 1. Copy this dataset ID: d_4dbb5c7995589918858f3c9c98b34706
  2. 2. Click on the button below
Open in Colab

Sample OpenAPI query

This code can be used to test a sample API query. It retrieves the data catalogue of this dataset. For a complete guide on query parameters and syntax, please refer to the API documentation. Try it out on your browser to see the response schema.

Adding an API key gives you higher rate limits and priority support. Log in to create your API key.

import requests
          
dataset_id = "d_4dbb5c7995589918858f3c9c98b34706"
url = "https://data.gov.sg/api/action/datastore_search?resource_id="  + dataset_id 
        
response = requests.get(url)
print(response.json())

Citation

This dataset can be reused and cited in research publications.

Precision Health Research, Singapore. (2026). PRECISE-SG100K Projects (2026) [Dataset]. data.gov.sg. Retrieved November 22, 2026 from https://data.gov.sg/datasets/d_4dbb5c7995589918858f3c9c98b34706/view

About this dataset

Contact

contact@precise.cris.sg

Created on

27 Jul 2026

Licence

Free forever for personal or commercial use, under the Open Data Licence.

Agency

Precision Health Research, Singapore